The diagnosis of septic disseminated intravascular coagulation (DIC) relies on clinical signs and symptoms, identification of the underlying disease and results of laboratory testing. Since no single test result alone can definitely establish or rule out the diagnosis, the laboratory diagnostics of septic DIC encompass a combination of tests for which simple diagnostic algorithms are now available. Global tests of haemostasis provide evidence of activation of blood coagulation and, ultimately, consumption of coagulation factors, but their diagnostic efficiency is as yet questionable. Fibrinolytic markers, namely D-dimer, reflect the extent of activation of both coagulation and fibrinolysis, so a normal value can be used in a ruling-out strategy. Decreased levels of the natural inhibitors are frequently observed in patients with septic DIC, but antithrombin and protein C measurements are not incorporated in any of the widely used diagnostic algorithms. Among the inflammatory biomarkers, procalcitonin is currently regarded as the gold standard to differentiate the type of infection and guide antibiotic therapy, but its clinical usefulness in identifying and predicting the outcome of patients with septic DIC is still circumstantial.
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Although the clinical spectrum of DIC is often heterogeneous and the balance between thrombosis (micro-or macrothrombosis) and bleeding (petechiae, ecchymoses, mucosal, skin and catheter haemorrhages) varies widely on an individual basis and according to the underlying cause, all bodily organs can be affected, such that multiorgan failure (MOF) is often a catastrophic end-point. In its most severe form, the combination of thrombosis and haemorrhage may trigger Waterhouse-Friderichsen syndrome (septicaemia and acute adrenal insufficiency), which is frequently observed in patients with fulminant meningococcal septicaemia. 5 The magnitude of the mutual clinical relationship between sepsis and DIC is reflected by epidemiological data attesting that DIC is a rather frequent complication in patients with sepsis (DIC is observed in up to 50% of patients with sepsis and is a strong predictor of mortality) and, on the other side of the coin, sepsis is by far the most frequent underlying condition identified in patients with DIC. 6 Although lipopolysaccharide (LPS), conventionally referred to as endotoxin, is recognised as the most potent microbial mediator implicated in the pathogenesis of sepsis and septic shock, 7 it
is not alone as a cause of the worst overall complications (MOF and DIC). 
Laboratory Diagnostics in Septic Disseminated Intravascular Coagulation
The diagnosis of septic DIC is possible using a combination of laboratory tests for which simple diagnostic algorithms have now become available. However, these tests can be used for diagnosing and monitoring DIC only when at least two main requisites are fulfilled:
identification of DIC at the earliest possible phase and availability in routine and, especially, urgent clinical settings. 12 Patients with DIC have a low or rapidly decreasing platelet count, prolonged coagulation tests, low plasma levels of coagulation factors and inhibitors and increased markers of fibrin formation and/or degradation, such as D-dimer or fibrin degradation products (see Table 1 ). Therefore, a reliable approach to the diagnosis of DIC is the use of a simple scoring system based on the combination of routinely available coagulation tests.
Scoring Cards for Disseminated Intravascular Coagulation
The SSC on DIC of the ISTH has developed a four-parameter scoring card for DIC for 'overt' and 'non-overt' DIC. The scoring for overt DIC is as follows:
• platelet count: >100x10 9 /l = 0, <100x10 9 /l = 1, <50x10 9 /l = 2;
• elevated fibrin degradation products: no increase = 0, moderate increase = 2, strong increase = 3;
• prothrombin time (PT) upper limit of reference range: <3 seconds = 0, >3 seconds = 1, >6 seconds = 2; and
• fibrinogen level: >100mg/dl = 0, <100mg/dl = 1.
Coagulation Disorders • platelet count: ≤120x10 9 /l = 1, ≤80x10 9 /l = 2, ≤50x10 9 /l = 3;
• elevated fibrin degradation products: ≥10µg/ml = 1, ≥20µg/ml = 2, ≥40µg/ml = 3; • PT: ≥1.25 = 1, ≥1.67 = 2; and • fibrinogen levels: ≤150mg/dl = 1, ≤100 mg/dl = 2.
An overall score of ≥4 or ≥7 is compatible with DIC in patients with or without haematological malignancies, respectively. 15 The rate of agreement in the diagnosis of DIC by ISTH and JMHW criteria was 67%;
only 2% of non-DIC patients by JMHW criteria were diagnosed with overt DIC by ISTH criteria, suggesting that the ISTH criteria for overt DIC may include typical cases of DIC.
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The Japanese Association for Acute Medicine (JAAM) DIC Study Group recently announced new DIC diagnostic criteria for critically ill patients, reaffirming the reliability of using a four-parameter scoring card that includes:
• inflammatory response syndrome criteria: ≥3 = 1, 0-2 = 0;
• platelet count: <80x10 9 /l or 50% decrease within 24 hours = 3, ≥80x10 9 /l, <120x10 9 /l or >30% decrease within 24 hours = 1 and >120x10 9 /l = 0; • PT: ≥1.2 = 1, <1.2 = 0; and • fibrin/fibrinogen degradation products: ≥25 mg/l = 3, ≥10 and <25mg/dl = 1, <10 = 0.
An overall score of ≥4 is compatible with DIC. 17 
Global Tests of Haemostasis
The PT is a simple, rapid and relatively inexpensive haemostatic test that explores the extrinsic and common pathways of blood coagulation. 21 Although its values have been reported to be prolonged in the vast majority of patients with DIC (up to 70%), the use of PT as a diagnostic test is questionable because elevations often occur in a later stage of the disease when the outcome of the patients may already be compromised. 22 The activated partial thromboplastin time (APTT) is a global clotting test sensitive to several plasma inhibitors and acquired or inherited deficiencies of coagulation factors of the intrinsic and common pathway. Prolonged APTT values have been reported in up to 50% of patients with DIC, but in the other 50% they can be normal or even shortened (mirroring the acute-phase-induced increase of von Willebrand factor). Accordingly, its clinical usefulness is limited in the diagnostics of DIC; it certainly cannot be used to rule out the diagnosis, and overall it is even more unreliable than the PT.
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Fibrinogen levels often decline in patients with DIC due to massive consumption of the protein entrapped within the thrombi. However, the overall sensitivity of plasma fibrinogen levels for the diagnosis of DIC is low, since the protein is an additional well-recognised acutephase reactant and its levels are often within the normal range for a long period of time, especially in patients with severe infections. Thus, hypofibrinogenaemia is frequently detected only in very severe cases of DIC, or in the advanced stages of the disease. In contrast to fibrinogen, platelet count is considered a very sensitive test in the diagnosis of DIC. Platelet count is strongly correlated with markers of thrombin generation, since thrombin-induced platelet aggregation is to a large extent responsible for platelet consumption.
Moreover, platelet count is not influenced by the acute-phase response, so overall it is more reliable than fibrinogen testing. However, since the normal platelet count varies between 150 and 
Consumption of Natural Inhibitors
The natural anticoagulants, especially antithrombin and protein C, are frequently reduced in patients with DIC, and they also have prognostic Laboratory Diagnostics in Septic Disseminated Intravascular Coagulation 
Waveform Analysis
The APTT is the most common test of haemostasis performed in 
Inflammatory Biomarkers
For a better understanding of the immunological dysregulation in sepsis, several biomarkers are now available for routine and urgent diagnostics, including CRP, differential blood counting, the cytokines IL-6, IL-8, TNF-α, procalcitonin and the LPS-binding protein (LBP). 42 However, only a few of these have a real impact throughout the managed care of patients with sepsis and therefore fulfil the clinical requirements.
Procalcitonin is a 116 amino acid protein with a sequence identical to that of the prohormone of calcitonin (32 amino acids). Under physiological conditions, hormonally active calcitonin is produced and secreted in the C cells of the thyroid gland after specific intracellular proteolytic procession of the prohormone procalcitonin. However, in severe bacterial infections and sepsis, extrathyroidal production of
Coagulation Disorders It should be noted that two recent meta-analyses of pooled data both concluded that procalcitonin cannot reliably differentiate sepsis from other non-infectious causes of systemic inflammatory response syndrome in critically ill adult patients, thus arguing against the widespread use of the procalcitonin test in critical care settings. 46, 47 Giamarellos-Bourboulis et al. earlier reported that procalcitonin can be regarded as an early prognostic marker of the advent of DIC and MOF, so its daily monitoring may be helpful in the follow-up of critically ill patients. 48 Boussekey et al. also observed that procalcitonin levels were increased in patients with communityacquired pneumonia who developed infection-related DIC during their intensive care unit stay. 49 Interestingly, Ucar et al. did not find any significant increase in the levels of TNF-α and serum amyloid A (SAA) in newborns with neonatal late-onset sepsis who developed DIC, but procalcitonin was markedly increased in all of these patients on days zero, four and eight. 50 LBP is an acute-phase protein involved in the endotoxin-mediated immune response. Although the overall diagnostic performance of this test is comparable to that of procalcitonin, LBP has slow kinetics of induction and elimination, and the severity of the inflammatory response is not well diagnosed. 51 ILs, especially IL-1 and IL-6, are biomarkers indicating the severity of the inflammatory response, but they are not specific for bacterial infection since they can be induced after surgery, autoimmune disorders, transplant rejection and viral infection. Immunosuppression also decreases the IL response. The kinetics of most ILs is also very fast; concentrations increase only briefly or intermittently and decline very quickly in sepsis, so their measurement is not superior to that of procalcitonin for the diagnosis of sepsis and may be unsuitable to monitor the clinical course of the disease. 51, 52 Finally, the measurements of most ILs is still challenging for a variety of pre-analytical/analytical reasons, and several instruments in the statistics laboratory are not equipped to deal with these tests.
The routine use of other traditional laboratory tests (e.g. leukocyte count, blood differential counting and CRP) is prompted by low cost, easy availability and historical practice rather than strong evidence.
However, their reliability is hampered by a protracted response with late peak levels, low specificity compared with procalcitonin, especially in patients with MOF, 49, 53, 54 and a reduced increase in patients undergoing steroid or other immunosuppressive therapies.
Moreover, unlike procalcitonin, the dynamics of CRP and blood differential counting have limited prognostic implication. 
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